Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · Real-Time Price · USD
8.16
+0.02 (0.25%)
Jun 24, 2025, 4:00 PM - Market closed
Regulus Therapeutics Market Cap
Regulus Therapeutics has a market cap or net worth of $616.99 million as of June 25, 2025. Its market cap has increased by 297.54% in one year.
Market Cap
616.99M
Enterprise Value
553.02M
1-Year Change
297.54%
Ranking
Category
Stock Price
$8.16
Market Cap Chart
Since December 31, 2012, Regulus Therapeutics's market cap has increased from $225.70M to $616.99M, an increase of 173.37%. That is a compound annual growth rate of 8.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2025 | 563.60M | 444.54% |
| Dec 31, 2024 | 103.50M | 299.61% |
| Dec 29, 2023 | 25.90M | 12.12% |
| Dec 30, 2022 | 23.10M | -15.69% |
| Dec 31, 2021 | 27.40M | -48.20% |
| Dec 31, 2020 | 52.90M | 184.41% |
| Dec 31, 2019 | 18.60M | 129.63% |
| Dec 31, 2018 | 8.10M | -92.51% |
| Dec 29, 2017 | 108.10M | -9.24% |
| Dec 30, 2016 | 119.10M | -73.90% |
| Dec 31, 2015 | 456.40M | -41.46% |
| Dec 31, 2014 | 779.60M | 152.54% |
| Dec 31, 2013 | 308.70M | 36.77% |
| Dec 31, 2012 | 225.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |